查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1208609

2023-2030 年全球胃球囊手術市場

Global Gastric Balloon Procedures Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

胃球囊手術的全球市場規模預計到 2023 年將達到 4945 萬美元，在預測期內（2023 年至 2030 年）以 12.4% 的複合年增長率增長。

胃球囊療法，又稱內窺鏡胃內球囊，將1至3個矽膠球囊置入患者胃部數月，使多餘體重減少約30%，從而減輕患者體重，是一種改善健康的方法。

市場動態

推動全球胃球囊手術市場的主要因素是：由於 2 型糖尿病發病率上升，胃球囊手術需求增加，其中肥胖是主要原因；這些因素包括肥胖人數增加，提高認識運動，以及導致新產品發布的技術進步。

健身和體質意識的提高以及全球肥胖人數的增加預計將導致新產品的開發並推動市場的增長。

胃球囊手術市場的驅動因素包括健身和結構意識的提高、技術進步的不斷增加、老年人口的增加、研發投資的激增、主要由肥胖引起的 2 型糖尿病病例數量的增加、新興市場的推動。市場醫療基礎設施的改善以及採用最新技術的新產品的改進。

胃氣球被廣泛用於減肥。 這些設備的日益普及導致政府加大了努力和資金投入。 這些資金將支持單層、雙層和三層胃球囊產品的生產。 隨著患有肥胖症的人數增加，這些胃氣球市場在全世界都在增長。 此外，預計主要製造商提供的技術先進的產品也將在市場增長中發揮重要作用。

2022 年 5 月 26 日，以醫生為主導的代謝健康和減肥解決方案公司 Reshape Lifesciences 今天宣布，它將推出虛擬護理全棧式交付，以安排以醫生為主導的全國遠程健康解決方案減肥指導。宣布與服務提供商 OpenLoop 達成協議。

使用胃氣球帶來的風險和安全問題預計會阻礙市場增長。

然而，用於胃球囊放置手術的矽膠球囊批准的嚴格規則和法規是抑制胃球囊手術市場增長的主要因素。 這些程序的高成本也是一個限制因素。

與使用這些胃氣球和導管相關的風險和安全問題可能會抑制生長。 與這些充滿鹽水或氣體的胃氣球相關的高風險可能會導致阻塞，需要通過手術來移除該裝置。 其他風險包括急性胰腺炎、過度充氣和胃壁潰瘍。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID，胃氣球手術市場遭受了巨大損失。 主要製造商已經啟動了各種研究和臨床試驗。 世界各地正在開展各種舉措、產品發布、合作和合併，以促進市場的增長。 例如，2022 年 10 月 31 日，以醫生為主導的代謝健康和減肥解決方案公司 ReShape Lifesciences 宣布，國際肥胖與代謝外科醫生聯合會 (IFSO) 和美國代謝與減肥外科醫生協會 (ASMBS) 將認識到 宣布發布更新的代謝和減肥手術新指南。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 提高對健身和體質的認識
      • 肥胖人口增加
    • 約束因素
      • 使用胃氣球時的安全問題
      • 成本高
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 單個胃氣球
  • 雙胃氣球
  • 三層胃氣球

第 8 章技術

  • 內窺鏡
  • 非內窺鏡

第9章通過填充

  • 充滿鹽水的胃氣球
  • 充氣胃氣球

第 10 章按容量分類

  • 可調節胃氣球
  • 不可調節的胃氣球

第 11 章最終用戶

  • 醫院
  • 門診手術中心
  • 醫務室

第12章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第13章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第14章公司簡介

  • Apollo Endosurgery Inc.
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • ReShape Lifesciences, Inc.
  • LEXEL S.R.L.
  • Medispar c.v.b.a.
  • Allurion
  • Helioscopie Medical Implants
  • Districlass Medical
  • ENDALIS
  • Accel Medical
  • Silimed, Inc.

第15章 DataM

簡介目錄
Product Code: DMMD64

Market Overview

The global gastric balloon procedures market size was valued at US$ 49.45 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 12.4% during the forecast period (2023-2030).

Gastric balloon procedures also called an endoscopic intragastric balloon, is the procedure of inserting 1 to 3 silicon balloons in the stomach of the patient for a few months so that they lose around 30% of excess weight, thereby improving the health condition of the patient.

Market Dynamics

The major factors driving the global gastric balloon procedures market are the rising demand for gastric balloon procedures owing to increasing incidences of type-2diabetes which is mainly caused due to obesity, increasing consciousness on fitness and structure, growing obese population across the globe,, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing consciousness on fitness and structure and growing obese population across the globe leading to the development of novel products are expected to drive the market's growth.

The gastric balloon procedures market is driven by increasing consciousness on fitness and structure, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of type-2 diabetes cases which is mainly caused due to obesity and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The gastric balloon procedures are used widely for weight loss. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce gastric balloon products such as single, dual and triple gastric balloons. The market for these gastric balloons is increasing worldwide due to the enhanced number of people suffering from obesity. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these gastric balloon procedures medications contribute to the market's growth. in May 26, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced its agreement with OpenLoop, virtual care full-stack delivery services provider, to arrange a physician-led, nationwide, telehealth solution for virtual weight loss coaching.

Risks and safety concerns associated with the use of these gastric balloons are expected to hamper the market's growth.

However strict rules and regulations for the approval of the silicone balloons utilized for procedure of gastric balloon placement is the major factor hindering the growth of the gastric balloon procedures market. High costs of these procedures is also a limiting factor.

The risks and safety concerns associated with the use of these gastric balloons or catheters are likely to hinder the growth. High risk related to these gastric balloons that are filled with either saline or gas can cause a blockage which requires surgery for the removal of device. Other risks are acute pancreatitis, over-inflation and ulcers in the stomach wall.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The gastric balloon procedures market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in October 31, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced that the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have issued novel guidelines that have been updated for Metabolic and Bariatric Surgery which include the Lap-Band.

Segment Analysis

The single gastric balloon segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The single gastric balloon segment is the highest market holder in the global gastric balloon procedures market. The global gastric balloon procedures market is segmented based on product type as single gastric balloon, dual gastric balloon and triple gastric balloon. The single gastric balloon segment is the largest market shareholder due to its increasing number of procedures utilizing single gastric ballons globally, increasing technological advancements and novel product launches.

Single gastric balloon is the most commonly used balloon for gastric balloon procedures which is easy to insert as this one time procedure where the doctor will place the catheter inside the stomach and then fill the balloon with either gas or saline water so the person may feel full after eating small amount of food. This balloon will then be removed after 6 months of placement. This whole procedure is done under direct supervision of endoscopy. The procedure involving single gastric balloon is easy to perform.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in November 21, 2022, Apollo Endosurgery, Inc., a minimally invasive medical devices provider for bariatric and gastrointestinal procedures, announced about its successful transition under the European Medical Device Regulation (MDR) of legacy products including for the BIB, OverStitch Systems and Orbera 365 intragastric balloons to CE Mark. The novel certificates were issued by British Standards Institute and are valid for five years.

Geographical Analysis

North America holds the largest market share in the global gastric balloon procedures market.

North America dominates the global gastric balloon procedures market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of gastric balloon procedures such as endoscopic or non-endoscopic like swallowing for weight loss, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the gastric balloon procedures market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in November 29, 2022, Apollo Endosurgery, Inc., a minimally invasive medical device provider company for bariatric and gastrointestinal procedures, announced about entering into an acquisition merger agreement with Boston Scientific Corporation, a medical technology provider company.

Competitive Landscape

The gastric balloon procedures market is moderately competitive with local and global companies' presence. Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar C.V.B.A, Allurion, Helioscopie Medical Implants, Districlass Medical, ENDALIS, Accel Medical, Silimed, Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in June 16, 2021, ReShape Lifesciences Inc., a weight-loss solutions provider announced its completion of the announced merger with Obalon Therapeutics. Obalon's name is changed to ReShape Lifesciences Inc. and company's combined common stock will initiate trading under the ticker symbol "RSLS".

ReShape Lifesciences, Inc.

Overview: ReShape Lifesciences is a metabolic health and weight loss-solutions provider company, providing an integrated portfolio of products and services that treat and manage obesity and metabolic disorders.

Product Portfolio:

Obalon Balloon System: It is the first and only gas-filled, swallowable, FDA-approved balloon system specially developed for weight-loss.

The global gastric balloon procedures market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing consciousness on fitness and structure
      • 4.1.1.2. Growing obese population
    • 4.1.2. Restraints:
      • 4.1.2.1. Safety concerns regarding the use of gastric balloons
      • 4.1.2.2. High cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Single Gastric Balloon*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Dual Gastric Balloon
  • 7.4. Triple Gastric Balloon

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 8.1.2. Market Attractiveness Index, By Placement
  • 8.2. Endoscopic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Non-Endoscopic

9. By Filling

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 9.1.2. Market Attractiveness Index, By Filling
  • 9.2. Saline-Filled Gastric Balloon*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Gas-Filled Gastric Balloon

10. By Volume

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 10.1.2. Market Attractiveness Index, By Volume
  • 10.2. Adjustable Gastric Balloon *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Non-Adjustable Gastric Balloon

11. By End-User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2. Market Attractiveness Index, By End-User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Clinics

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Products Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Apollo Endosurgery Inc. *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. ReShape Lifesciences, Inc.
  • 14.3. LEXEL S.R.L.
  • 14.4. Medispar c.v.b.a.
  • 14.5. Allurion
  • 14.6. Helioscopie Medical Implants
  • 14.7. Districlass Medical
  • 14.8. ENDALIS
  • 14.9. Accel Medical
  • 14.10. Silimed, Inc.

LIST NOT EXHAUSTIVE

15. Global Gastric Balloon Procedures Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Medications
  • 15.3. Contact Us